Biotech · Private company
CASI pharmaceuticals, Inc.
Track this companyFree. Adds CASI pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ENMD-2076Phase 2 · Advanced Adult Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- ENMD-2076Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- ENMD-2076Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar CarcinomaPHASE2 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02234986 · fetched Nov 12, 2026
- Study of ENMD-2076 in Patients With Multiple MyelomaPHASE1 · COMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00806065 · fetched Nov 12, 2026
- A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced CancerPHASE1 · COMPLETED · started Apr 1, 2008ClinicalTrials.gov NCT00658671 · fetched Nov 12, 2026